News
26 Apr 2021
Bortezomib Injection 3.5 mg vial DCP application
Onko Koçsel is proud that Bortezomib Injection 3.5 mg vial DCP
application has been successfully accepted by EMA member countries on March,
2021. Onko Koçsel is open for collaboration within and outside EU countries.
Mentioned Companies
Onko Ilac Sanayi ve Ticaret A.S.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance